Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


15 abril 2022

Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke

Juliane Schweizer, Markus Arnold, Inke R. König, Antonela Bicvic, Laura P. Westphal, Valerie Schütz, Corinne Inauen, Natalie Scherrer, Andreas Luft, Marian Galovic, Carolina Ferreira Atuesta, Thomas Pokorny, Marcel Arnold, Urs Fischer, Leo H. Bonati, Gian Marco De Marchis, Timo Kahles, Krassen Nedeltchev, Carlo W. Cereda, Georg Kägi, Alejandro Bustamante, Joan Montaner, Georg Ntaios, Dimitrios Sagris, Christian Foerch, Katharina Spanaus, Arnold von Eckardstein, and Mira Katan

Background Midregional pro-atrial natriuretic peptide (MR-proANP) is a promising biomarker to differentiate the underlying etiology of acute ischemic stroke (AIS).

15 abril 2022

Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

Ángel Arenal, Pablo Ávila, Javier Jiménez-Candil, Luis Tercedor, David Calvo, Fernando Arribas, Javier Fernández-Portales, José Luis Merino, Antonio Hernández-Madrid, Francisco J. Fernández-Avilés, and Antonio Berruezo

Background In patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator (ICD), catheter ablation and antiarrhythmic drugs (AADs) reduce ICD shocks, but the most effective approach remains uncertain.

15 abril 2022

Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension

Yu-Ping Zhou, Yun-Peng Wei, Yin-Jian Yang, Xi-Qi Xu, Tao Wu, Chao Liu, Ke-Yi Mei, Fu-Hua Peng, Hai-Ping Wang, Kai Sun, Jing-Yi Li, Hui-Fang Wang, Meng-Tao Li, Duo-Lao Wang, Qi Miao, Xin Jiang, and Zhi-Cheng Jing

Background Percutaneous transluminal pulmonary angioplasty (PTPA) is a treatment modality for chronic thromboembolic pulmonary hypertension, but whether it can be applied to Takayasu arteritis–associated pulmonary hypertension (TA-PH), another chronic obstructive pulmonary vascular disease, remains unclear.

15 junio 2022

4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation

Pavel Osmancik, Dalibor Herman, Petr Neuzil, Pavel Hala, Milos Taborsky, Petr Kala, Martin Poloczek, Josef Stasek, Ludek Haman, Marian Branny, Jan Chovancik, Pavel Cervinka, Jiri Holy, Tomas Kovarnik, David Zemanek, Stepan Havranek, Vlastimil Vancura, Petr Peichl, Petr Tousek, Veronika Lekesova, Jiri Jarkovsky, Martina Novackova, Klara Benesova, Petr Widimsky, Vivek Y. Reddy, and on behalf of the PRAGUE-17 Trial Investigators

Background The PRAGUE-17 (Left Atrial Appendage Closure vs Novel Anticoagulation Agents in Atrial Fibrillation) trial demonstrated that left atrial appendage closure (LAAC) was noninferior to nonwarfarin direct oral anticoagulants (DOACs) for preventing major neurological, cardiovascular, or bleeding events in patients with atrial fibrillation (AF) who were at high risk.

15 enero 2022

Reintervention and Survival After Transcatheter Pulmonary Valve Replacement

Doff B. McElhinney, Yulin Zhang, Daniel S. Levi, Stanimir Georgiev, Elżbieta Katarzyna Biernacka, Bryan H. Goldstein, Shabana Shahanavaz, Athar M. Qureshi, Allison K. Cabalka, Holly Bauser-Heaton, Alejandro J. Torres, Brian H. Morray, Aimee K. Armstrong, Oscar Millan-Iturbe, Lynn F. Peng, Jamil A. Aboulhosn, Witold Rużyłło, Felix Berger, Lars Sondergaard, Dietmar Schranz, John P. Cheatham, Thomas K. Jones, Peter Ewert, and Stephan Schubert

Background Transcatheter pulmonary valve (TPV) replacement (TPVR) has become the standard therapy for postoperative pulmonary outflow tract dysfunction in patients with a prosthetic conduit/valve, but there is limited information about risk factors for death or reintervention after this procedure.

15 enero 2022

Maternal Cardiac Function at Midgestation and Development of Preeclampsia

Elena Gibbone, Iulia Huluta, Alan Wright, Kypros H. Nicolaides, and Marietta Charakida

Background Preeclampsia (PE) is an independent risk factor for adverse maternal cardiovascular outcomes. The role of maternal cardiac function in the pathophysiology of PE remains unclear.

15 enero 2022

Magnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy–Induced Gastrointestinal Injury

Yaling Han, Zhuan Liao, Yi Li, Xianxian Zhao, Shuren Ma, Dan Bao, Miaohan Qiu, Jie Deng, Jinhai Wang, Peng Qu, Chunmeng Jiang, Shaobin Jia, Shaoqi Yang, Leisheng Ru, Jia Feng, Wei Gao, Yonghui Huang, Ling Tao, Ying Han, Kan Yang, Xiaoyan Wang, Wenjuan Zhang, Bangmao Wang, Yue Li, Youlin Yang, Junxia Li, Jiangqiu Sheng, Yitong Ma, Min Cui, Sicong Ma, Xiaozeng Wang, Zhaoshen Li, and Gregg W. Stone

Background Gastrointestinal bleeding is the most frequent major complication of antiplatelet therapy. In patients at low bleeding risk, however, clinically overt gastrointestinal bleeding is relatively uncommon.

15 enero 2022

Evolution of Incidence, Management, and Outcomes Over Time in Sports-Related Sudden Cardiac Arrest

Nicole Karam, Louis Pechmajou, Kumar Narayanan, Wulfran Bougouin, Ardalan Sharifzadehgan, Soraya Anys, Orianne Weizman, David Perrot, Victor Waldmann, Frankie Beganton, Marie-Cécile Perier, Julien Rischard, Thomas Loeb, Jean-Marc Agostinucci, Eric Lecarpentier, Patricia Jabre, Daniel Jost, Florence Dumas, Alain Cariou, Xavier Jouven, and Eloi Marijon

Background Major efforts have been made to reduce the burden of sports-related sudden cardiac arrest (SrSCA). The extent to which the incidence, management, and outcomes changed over time has not been investigated.

15 febrero 2022

Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention

Ralf E. Harskamp, Alexander C. Fanaroff, Renato D. Lopes, Daniel M. Wojdyla, Shaun G. Goodman, Laine E. Thomas, Ronald Aronson, Stephan Windecker, Roxana Mehran, Christopher B. Granger, and John H. Alexander

Background The use of apixaban instead of vitamin K antagonists (VKA) as well as dropping aspirin results in less bleeding and comparable ischemic events in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention treated with a P2Y12 inhibitor.

15 febrero 2022

Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair

Michael I. Brener, Philipp Lurz, Jörg Hausleiter, Josep Rodés-Cabau, Neil Fam, Susheel K. Kodali, Karl-Philipp Rommel, Guillem Muntané-Carol, Mara Gavazzoni, Tamim M. Nazif, Alberto Pozzoli, Hannes Alessandrini, Azeem Latib, Luigi Biasco, Daniel Braun, Eric Brochet, Paolo Denti, Edith Lubos, Sebastian Ludwig, Daniel Kalbacher, Rodrigo Estevez-Loureiro, Kim A. Connelly, Christian Frerker, Edwin C. Ho, Jean-Michel Juliard, Claudia Harr, Vanessa Monivas, Georg Nickenig, Giovanni Pedrazzini, François Philippon, Fabien Praz, Rishi Puri, Joachim Schofer, Horst Sievert, Gilbert H.L. Tang, Martin Andreas, Holger Thiele, Matthias Unterhuber, Dominique Himbert, Marina Ureña Alcázar, Ralph Stephan Von Bardeleben, Stephan Windecker, Mirjam G. Wild, Francesco Maisano, Martin B. Leon, Maurizio Taramasso, and Rebecca T. Hahn

Background The right ventricular (RV)–pulmonary arterial (PA) coupling ratio relates the efficiency with which RV stroke work is transferred into the PA. Lower ratios indicate an inadequate RV contractile response to increased afterload.

15 febrero 2022

A Score to Assess Mortality After Percutaneous Mitral Valve Repair

Sergio Raposeiras-Roubin, Marianna Adamo, Xavier Freixa, Dabit Arzamendi, Tomas Benito-González, Antonio Montefusco, Isaac Pascual, Luis Nombela-Franco, Josep Rodes-Cabau, Mony Shuvy, Antonio Portolés-Hernández, Cosmo Godino, Berenice Caneiro-Queija, Laura Lupi, Ander Regueiro, Chin Hion Li, Felipe Fernández-Vázquez, Simone Frea, Pablo Avanzas, Gabriela Tirado-Conte, Jean-Michel Paradis, Alona Peretz, Vanessa Moñivas, Jose A. Baz, Michele Galasso, Luca Branca, Laura Sanchís, Lluís Asmarats, Carmen Garrote-Coloma, Filippo Angelini, Victor León, Eduardo Pozo, Alberto Alperi, Ronen Beeri, Dario Cani, Manel Sabaté, Estefanía Fernández-Peregrina, Javier Gualis, Pier Paolo Bocchino, Salvatore Curello, Emad Abu-Assi, Andrés Íñiguez-Romo, Francesco Bedogni, Antonio Popolo Rubbio, Luca Testa, Carmelo Grasso, and Rodrigo Estévez-Loureiro

Background Risk stratification for transcatheter edge-to-edge mitral valve repair (TEER) is paramount in the decision-making process for treating severe mitral regurgitation (MR).

15 marzo 2022

Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation

Norman Mangner, David del Val, Mohamed Abdel-Wahab, Lisa Crusius, Eric Durand, Nikolaj Ihlemann, Marina Urena, Costanza Pellegrini, Francesco Giannini, Tomasz Gasior, Wojtek Wojakowski, Martin Landt, Vincent Auffret, Jan Malte Sinning, Asim N. Cheema, Luis Nombela-Franco, Chekrallah Chamandi, Francisco Campelo-Parada, Erika Munoz-Garcia, Howard C. Herrmann, Luca Testa, Won-Keun Kim, Juan Carlos Castillo, Alberto Alperi, Didier Tchetche, Antonio L. Bartorelli, Samir Kapadia, Stefan Stortecky, Ignacio Amat-Santos, Harindra C. Wijeysundera, John Lisko, Enrique Gutiérrez-Ibanes, Vicenç Serra, Luisa Salido, Abdullah Alkhodair, Ugolino Livi, Tarun Chakravarty, Stamatios Lerakis, Victoria Vilalta, Ander Regueiro, Rafael Romaguera, Utz Kappert, Marco Barbanti, Jean-Bernard Masson, Frédéric Maes, Claudia Fiorina, Antonio Miceli, Susheel Kodali, Henrique B. Ribeiro, Jose Armando Mangione, Fabio Sandoli de Brito, Guglielmo Mario Actis Dato, Francesco Rosato, Maria-Cristina Ferreira, Valter Correia de Lima, Alexandre Siciliano Colafranceschi, Alexandre Abizaid, Marcos Antonio Marino, Vinicius Esteves, Julio Andrea, Roger R. Godinho, Fernando Alfonso, Helene Eltchaninoff, Lars Søndergaard, Dominique Himbert, Oliver Husser, Azeem Latib, Hervé Le Breton, Clement Servoz, Isaac Pascual, Saif Siddiqui, Paolo Olivares, Rosana Hernandez-Antolin, John G. Webb, Sandro Sponga, Raj Makkar, Annapoorna S. Kini, Marouane Boukhris, Philippe Gervais, Mélanie Côté, David Holzhey, Axel Linke, and Josep Rodés-Cabau

Background The optimal treatment of patients developing infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is uncertain.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.